February 18, 2026: Ozempic Manufacturer Runs $20 Million Super Bowl Ad Despite Mounting Lawsuits Novo Nordisk, which makes the GLP-1 drugs Ozempic and Wegovy, aired a high-profile ad during Super Bowl LX that reportedly cost more than $20 million
Your doctor needs to confirm you met ONE of these criteria when you first started taking a GLP-1: Path 1: Higher BMI BMI of 35 or higher No other health conditions required Example: You started Wegovy in 2024 with BMI 37, and now your BMI is 33 you still qualify
Recent advancements have led to the development of GIP medications, which are being studied for their potential in weight management and metabolic regulation
Rosamond Johnson and James Weldon Johnson
Dipeptidyl peptidase IV inhibitory activity of terminalia arjuna attributes to its cardioprotective effects in experimental diabetes: In silico, in vitro and in vivo analyses
Patients with IBD are approximately 6 times more likely to develop colorectal cancer than those without IBD
:max_bytes(150000):strip_icc():focal(749x0:751x2)/Mans4-Gallbladder-Gets-Infected-from-GLP-1-042726-95779718fd494bd0a6af2a98bcafc118.jpg)
